While there no therapies approved for sarcoidosis-associated pulmonary hypertension (SAPH), pulmonary hypertension-specific therapies may help ease right heart dysfunction…
Articles by Patricia Inácio, PhD
The investigational therapy ATYR1923 for pulmonary sarcoidosis may help decrease lung inflammation by halting the infiltration of immune…
A literature review of research performed in specific populations from countries worldwide estimated a heritability of 60 to 70 percent…
Middle-aged adults with impaired lung function, such as people with sarcoidosis, are at higher risk of dementia and mild cognitive…
Cardiac arrhythmias are increasing among sarcoidosis patients, and they are linked with higher hospital admission and mortality rates,…
aTyr Pharma, which developing therapies to modulate immune pathways involved in lung diseases, has announced an upcoming Phase 1b/2a…
The levels of two blood-circulating microRNAs, called microRNA-126 and microRNA-223, may work as new biomarkers for cardiac sarcoidosis,…
Infection from the bacteria Propionibacterium acnes is found frequently and at high rates in the lymph nodes of sarcoidosis patients and…
A small study of a group of patients in Canada who were showing the first signs of sarcoidosis suggests that…
Researchers are developing a new positron emission tomography (PET) scanner capable of imaging the whole body that promises to significantly…